-
Je něco špatně v tomto záznamu ?
Phage therapy of wound-associated infections
A. Zyman, A. Górski, R. Międzybrodzki
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- antibakteriální látky terapeutické užití MeSH
- Bacteria MeSH
- bakteriální infekce * terapie MeSH
- bakteriofágy * MeSH
- fágová terapie * metody MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Phages are viruses which can specifically infect bacteria, resulting in their destruction. Bacterial infections are a common complication of wound healing, and experimental evidence from animal models demonstrates promising potential for phage-dependent eradication of wound-associated infections. The studies discussed suggest that phage therapy may be an effective treatment, with important advantages over some current antibacterial treatments. Phage cocktails, as well as co-administration of phages and antibiotics, have been reported to minimise bacterial resistance. Further, phage-antibiotic synergism has been reported in some studies. The ideal dose of phages is still subject to debate, with evidence for both high and low doses to yield therapeutic effects. Novel delivery methods, such as hydrogels, are being explored for their advantages in topical wound healing. There are more and more Good Manufacturing Practice facilities dedicated to manufacturing phage products and phage therapy units across the world, showing the changing perception of phages which is occurring. However, further research is needed to secure the place of phages in modern medicine, with some scientists calling upon the World Health Organisation to help promote phage therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22013093
- 003
- CZ-PrNML
- 005
- 20240416145021.0
- 007
- ta
- 008
- 220504s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-021-00946-1 $2 doi
- 035 __
- $a (PubMed)35028881
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zyman, Anna $u Pharmacology Undergraduate Programme, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, University Walk, Bristol, BS8 1TD, UK
- 245 10
- $a Phage therapy of wound-associated infections / $c A. Zyman, A. Górski, R. Międzybrodzki
- 520 9_
- $a Phages are viruses which can specifically infect bacteria, resulting in their destruction. Bacterial infections are a common complication of wound healing, and experimental evidence from animal models demonstrates promising potential for phage-dependent eradication of wound-associated infections. The studies discussed suggest that phage therapy may be an effective treatment, with important advantages over some current antibacterial treatments. Phage cocktails, as well as co-administration of phages and antibiotics, have been reported to minimise bacterial resistance. Further, phage-antibiotic synergism has been reported in some studies. The ideal dose of phages is still subject to debate, with evidence for both high and low doses to yield therapeutic effects. Novel delivery methods, such as hydrogels, are being explored for their advantages in topical wound healing. There are more and more Good Manufacturing Practice facilities dedicated to manufacturing phage products and phage therapy units across the world, showing the changing perception of phages which is occurring. However, further research is needed to secure the place of phages in modern medicine, with some scientists calling upon the World Health Organisation to help promote phage therapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a Bacteria $7 D001419
- 650 12
- $a bakteriální infekce $x terapie $7 D001424
- 650 12
- $a bakteriofágy $7 D001435
- 650 12
- $a fágová terapie $x metody $7 D000071059
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Górski, Andrzej $u Bacteriophage Laboratory, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland. andrzej.gorski@hirszfeld.pl $u Phage Therapy Unit, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland. andrzej.gorski@hirszfeld.pl $u Infant Jesus Hospital, Medical University of Warsaw, 02-005, Warsaw, Poland. andrzej.gorski@hirszfeld.pl $1 https://orcid.org/0000000208636041
- 700 1_
- $a Międzybrodzki, Ryszard $u Bacteriophage Laboratory, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland $u Phage Therapy Unit, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland $u Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, 02-006, Warsaw, Poland $1 https://orcid.org/0000000173797290
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 67, č. 2 (2022), s. 193-201
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35028881 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220504 $b ABA008
- 991 __
- $a 20240416145018 $b ABA008
- 999 __
- $a ok $b bmc $g 1796131 $s 1164301
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 67 $c 2 $d 193-201 $e 20220113 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20220504